<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01728597</url>
  </required_header>
  <id_info>
    <org_study_id>CMR-12-TECH-02</org_study_id>
    <nct_id>NCT01728597</nct_id>
  </id_info>
  <brief_title>Non-contrast Enhanced Cardiac Magnetic Resonance Normal Values and Imaging Protocols</brief_title>
  <acronym>CMR-TECH</acronym>
  <official_title>Optimization of Non-contrast Enhanced 1.5 Tesla and 3 Tesla Cardiac Magnetic Resonance Imaging Techniques and Acquisition of Normal Values</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Graz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Amt der Steiermärkischen Landesregierung, Abteilung 3</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of Graz</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      One of the main problems in cardiac magnetic resonance (MR) investigations is the strong
      dependence of the achieved image quality on optimal settings of sequence parameters and
      anatomical and physiological situations and it is well known that the diagnostic impact of
      cardiac MR investigations crucially depends on the adaption of imaging protocols to patients'
      state and ability to cooperate.

      The aim of the present study is the evaluation and optimization of various 1.5 Tesla and 3
      Tesla cardiac MR investigation protocols without application of contrast agent as well as the
      acquisition of normal values for new cardiac MR images techniques:

        -  normal myocardial morphology: T1-, T2- and T2*-weighted imaging and acquisition of
           normal values of magnetic relaxation times (sequence- and protocol dependent),

        -  normal cardiac function: systolic and diastolic function (sequence- and protocol
           dependent),

        -  coronary artery imaging: feasibility to evaluate length, diameter and blood flow
           (sequence- and protocol dependent),

        -  normal blood flow topologies in the heart and the surrounding great vessels: 2D- and 3D
           blood flow imaging and evaluation techniques (sequence- and protocol dependent).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>cardiac volumes</measure>
    <time_frame>up to 1 week</time_frame>
    <description>volumes of cardiac chambers in the cardiac cycle [ml], sequence- and protocol dependent</description>
  </primary_outcome>
  <primary_outcome>
    <measure>cardiac performance</measure>
    <time_frame>up to 1 week</time_frame>
    <description>ejection fraction of cardiac chambers [%], sequence- and protocol dependent</description>
  </primary_outcome>
  <primary_outcome>
    <measure>cardiac muscle mass</measure>
    <time_frame>up to 1 week</time_frame>
    <description>systolic and end-diastolic mass of cardiac chambers [g], sequence- and protocol dependent</description>
  </primary_outcome>
  <primary_outcome>
    <measure>coronary artery anatomy</measure>
    <time_frame>up to 1 week</time_frame>
    <description>length and diameter [mm], sequence-, and protocol dependent</description>
  </primary_outcome>
  <primary_outcome>
    <measure>blood flow velocity</measure>
    <time_frame>up to 1 week</time_frame>
    <description>maximum, minimum and average velocity [cm/s], sequence-, and protocol dependent</description>
  </primary_outcome>
  <primary_outcome>
    <measure>blood flow vorticity</measure>
    <time_frame>up to 1 week</time_frame>
    <description>number of vortices of blood flow in the heart and surrounding great vessels, sequence and protocol dependent</description>
  </primary_outcome>
  <primary_outcome>
    <measure>blood flow timing</measure>
    <time_frame>up to 1 week</time_frame>
    <description>time points of characteristic blood flow patterns in the heart and surrounding great vessels in the cardiac cycle [ms], sequence-, and protocol dependent</description>
  </primary_outcome>
  <primary_outcome>
    <measure>magnetic relaxation times</measure>
    <time_frame>up to 1 week</time_frame>
    <description>systolic and diastolic T1, T2, T2* [ms], sequence- and protocol dependent</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>healthy volunteers</arm_group_label>
    <description>MR compliant volunteers with no history of cardiovascular diseases</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        healthy volunteers
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  No history of cardiac or pulmonary diseases

          -  ability to give informed consent

        Exclusion Criteria:

          -  General MR exclusion criteria eg. patients with metal devices or other magnetic
             material in or on the subjects body which will be hazardous for MR investigation (e.g.
             heart pace-maker, brain aneurysm clip, nerve stimulators, electrodes, penile implants,
             coloured contact lenses, patch to deliver medications through the skin, any metal
             implants as rods, joints, plates, pins, screws, nails or clips, embolization coil, or
             any metal fragments or shrapnel in the body),

          -  pregnancy,

          -  claustrophobia.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ursula Reiter, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical Unitersity Graz, Department of Radiology, Division of General Radiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ursula Reiter, PhD</last_name>
    <phone>+43-316-385</phone>
    <phone_ext>83347</phone_ext>
    <email>ursula.reiter@klinikum-graz.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michael Fuchsjäger, Prof. Dr.</last_name>
    <phone>+43-316-385</phone>
    <phone_ext>2411</phone_ext>
    <email>michael.fuchsjaeger@medunigraz.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical Unitersity Graz, Department of Radiology, Division of General Radiology</name>
      <address>
        <city>Graz</city>
        <state>Styria</state>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Fuchsjäger, Prof. Dr.</last_name>
      <phone>+43-316-385</phone>
      <phone_ext>2411</phone_ext>
      <email>michael.fuchsjaeger@medunigraz.at</email>
    </contact>
    <contact_backup>
      <last_name>Ursula Reiter, PhD</last_name>
      <phone>+43-316-385</phone>
      <phone_ext>83347</phone_ext>
      <email>ursula.reiter@klinikum-graz.at</email>
    </contact_backup>
    <investigator>
      <last_name>Ursula Reiter, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gert Reiter, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ralph Maderthaner, OA Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Helmut Schöllnast, Prof. Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Fuchsjäger, Prof. Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <results_reference>
    <citation>Reiter U, Reiter G, Dorr K, Greiser A, Maderthaner R, Fuchsjäger M. Normal diastolic and systolic myocardial T1 values at 1.5-T MR imaging: correlations and blood normalization. Radiology. 2014 May;271(2):365-72. doi: 10.1148/radiol.13131225. Epub 2013 Dec 6.</citation>
    <PMID>24475837</PMID>
  </results_reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 3, 2012</study_first_submitted>
  <study_first_submitted_qc>November 13, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2012</study_first_posted>
  <last_update_submitted>January 31, 2018</last_update_submitted>
  <last_update_submitted_qc>January 31, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Graz</investigator_affiliation>
    <investigator_full_name>Ursula Reiter</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>no history of cardiovascular diseases</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

